A phase I/II study to evaluate the ability of decitabine and panobinostat to improve temozolomide chemosensitivity in metastatic melanoma.
Chang Xia
No relevant relationships to disclose
Douglas Earl Laux
No relevant relationships to disclose
Jeremy Michael Deutsch
No relevant relationships to disclose
Melanie Frees
No relevant relationships to disclose
Brian Smith
No relevant relationships to disclose
Raymond J. Hohl
No relevant relationships to disclose
Mohammed M. Milhem
Research Funding - Novartis